Inventor · disambiguated record
Amha Hewet
Also filed as: HEWET AMHA
11 granted patents·4 pending applications·47 citations·filing 2013–2024
88Inventor score
Files withAMBRX INC15
Top patents by PatentIndex Score
15 records- 0196US10253083B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted Apr 9, 2019·11 cites·20 claims
- 0295US10751391B2Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acidAMBRX INC·Filed 2019·Granted Aug 25, 2020·6 cites·24 claims
- 0394US10702588B2Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chainAMBRX INC·Filed 2018·Granted Jul 7, 2020·7 cites·20 claims
- 0494US9567386B2Therapeutic uses of modified relaxin polypeptidesAMBRX INC·Filed 2013·Granted Feb 14, 2017·14 cites·12 claims
- 0592US9962450B2Method of treating heart failure with modified relaxin polypeptidesAMBRX INC·Filed 2016·Granted May 8, 2018·9 cites·21 claims
- 0687US2024189392A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2023·Application pending·0 cites
- 0781US11786578B2Modified relaxin polypeptides and their usesAMBRX INC·Filed 2022·Granted Oct 17, 2023·0 cites·19 claims
- 0881US2023028168A1Modified Relaxin Polypeptides and Their UsesAMBRX INC·Filed 2022·Application pending·0 cites
- 0980US2025002595A1Anti-CD70 Antibody Drug ConjugatesAMBRX INC·Filed 2024·Application pending·0 cites
- 1075US12037405B2Anti-CD70 antibody drug conjugatesAMBRX INC·Filed 2022·Granted Jul 16, 2024·0 cites·19 claims
- 1173US11311605B2Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Apr 26, 2022·0 cites·24 claims
- 1272US11439710B2Nucleic acids encoding modified relaxin polypeptidesAMBRX INC·Filed 2020·Granted Sep 13, 2022·0 cites·20 claims
- 1368US11459392B2Anti-CD70 antibody drug conjugatesAMBRX INC·Filed 2018·Granted Oct 4, 2022·0 cites·16 claims
- 1456US10208123B2Anti-CD70 antibody drug conjugatesAMBRX INC·Filed 2013·Granted Feb 19, 2019·0 cites·4 claims
- 1543US2015152187A1Anti-PSMA Antibodies Conjugated to Nuclear Receptor Ligand PolypeptidesAMBRX INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amha Hewet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →